Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19
Authors
Keywords
COVID-19, Sodium glucose Co-Transporter-2 inhibition, Dapagliflozin, Endothelin antagonism, Ambrisentan
Journal
PULMONARY PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages 102035
Publisher
Elsevier BV
Online
2021-04-30
DOI
10.1016/j.pupt.2021.102035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
- (2020) Thomas A. Zelniker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- CT imaging features of 34 patients infected with COVID-19
- (2020) Litao Zhang et al. CLINICAL IMAGING
- An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement
- (2020) J.C.L. Rodrigues et al. CLINICAL RADIOLOGY
- Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
- (2020) Celestino Sardu et al. DIABETES CARE
- Myocardial localization of coronavirus in COVID‐19 cardiogenic shock
- (2020) Guido Tavazzi et al. EUROPEAN JOURNAL OF HEART FAILURE
- Pathogenesis of COVID-19 from a cell biology perspective
- (2020) Robert J. Mason EUROPEAN RESPIRATORY JOURNAL
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
- (2020) Matt Arentz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT
- (2020) Min Lang et al. LANCET INFECTIOUS DISEASES
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
- (2020) Annemarie B Docherty et al. BMJ-British Medical Journal
- Covid-19 and acute kidney injury in hospital: summary of NICE guidelines
- (2020) Nicholas M Selby et al. BMJ-British Medical Journal
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Potential Effects of Coronaviruses on the Cardiovascular System
- (2020) Mohammad Madjid et al. JAMA Cardiology
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
- (2020) Frederik C. Enevoldsen et al. Journal of Clinical Medicine
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
- (2020) Liuliu Yang et al. Cell Stem Cell
- Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19
- (2020) Matteo Pagnesi et al. HEART
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
- (2020) Benjamin T Bradley et al. LANCET
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
- (2020) Luca Carsana et al. LANCET INFECTIOUS DISEASES
- Extrapulmonary manifestations of COVID-19
- (2020) Aakriti Gupta et al. NATURE MEDICINE
- COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
- (2020) Masataka Nishiga et al. Nature Reviews Cardiology
- New-Onset Diabetes in Covid-19
- (2020) Francesco Rubino et al. NEW ENGLAND JOURNAL OF MEDICINE
- muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial
- (2020) Ing Ni Lu et al. Trials
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
- (2020) Emma Barron et al. Lancet Diabetes & Endocrinology
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Immunopathology of Hyperinflammation in COVID-19
- (2020) Joshua N. Gustine et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
- (2020) Matthias P. Nägele et al. ATHEROSCLEROSIS
- StopCOVID cohort: An observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID-19 infection
- (2020) Daniel Munblit et al. CLINICAL INFECTIOUS DISEASES
- Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States
- (2020) Michael W Fried et al. CLINICAL INFECTIOUS DISEASES
- High burden of acute kidney injury in COVID-19 pandemic: systematic review and meta-analysis
- (2020) Camila Barbosa Oliveira et al. JOURNAL OF CLINICAL PATHOLOGY
- Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
- (2020) Niki Katsiki et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- SARS-CoV-2 renal tropism associates with acute kidney injury
- (2020) Fabian Braun et al. LANCET
- Lifting the mask on neurological manifestations of COVID-19
- (2020) Alessandro Pezzini et al. Nature Reviews Neurology
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review
- (2020) Yasser Sakr et al. Annals of Intensive Care
- Swollen heart in COVID‐19 patients who progress to critical illness: a perspective from echo‐cardiologists
- (2020) Yingxian Liu et al. ESC Heart Failure
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Post-Infectious Myocardial Infarction: New Insights for Improved Screening
- (2019) Alain Putot et al. Journal of Clinical Medicine
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelin: 30 Years From Discovery to Therapy
- (2019) Matthias Barton et al. HYPERTENSION
- Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysis
- (2019) Jan Menne et al. PLOS MEDICINE
- SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
- (2018) Subodh Verma et al. DIABETOLOGIA
- MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?
- (2018) Russell L Esterline et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease
- (2018) Patrick Mallia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms
- (2018) Sarah J. Mancini et al. Scientific Reports
- Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
- (2018) Julia A. Critchley et al. DIABETES CARE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cells upon activation promote endothelin 1 production in monocytes via IFN-γ and TNF-α
- (2017) Shoshi Shinagawa et al. Scientific Reports
- Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?
- (2017) Katina D. Hulme et al. Frontiers in Microbiology
- Endothelin-1 and the kidney
- (2016) Carmen De Miguel et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis
- (2016) John-David Aubert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stress Induced Hyperglycemia and the Subsequent Risk of Type 2 Diabetes in Survivors of Critical Illness
- (2016) Mark P. Plummer et al. PLoS One
- Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects
- (2015) Kathrin Gerlach et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inflammation and plaque vulnerability
- (2015) G. K. Hansson et al. JOURNAL OF INTERNAL MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis
- (2015) Tinazzi Elisa et al. Journal of Immunology Research
- The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
- (2014) Agata Kowalczyk et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Endothelin and endothelin antagonists in chronic kidney disease
- (2014) Donald E Kohan et al. KIDNEY INTERNATIONAL
- Bosentan as Rescue Treatment in Refractory Hypoxemia and Pulmonary Hypertension in a Patient with ARDS and H7N9 Influenza Virus Infection
- (2014) Qiang Guo et al. LUNG
- Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
- (2013) Vaibhav B. Patel et al. CLINICAL SCIENCE
- The road from AKI to CKD: the role of endothelin
- (2013) Neeraj Dhaun et al. KIDNEY INTERNATIONAL
- Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury
- (2013) Richard A. Zager et al. KIDNEY INTERNATIONAL
- Metformin reduces airway glucose permeability and hyperglycaemia-inducedStaphylococcus aureusload independently of effects on blood glucose
- (2013) James P Garnett et al. THORAX
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
- (2009) Jin-Kui Yang et al. ACTA DIABETOLOGICA
- Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats
- (2009) Y. Chen et al. EUROPEAN RESPIRATORY JOURNAL
- Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
- (2009) Ronald J. Oudiz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of endothelin-1 in acute lung injury
- (2009) Alejandro P. Comellas et al. Translational Research
- Endothelin-A Receptor Inhibition After Cardiopulmonary Bypass: Cytokines and Receptor Activation
- (2008) Rachael L. Ford et al. ANNALS OF THORACIC SURGERY
- Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
- (2008) Nazzareno Galiè et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started